Amedisys, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0234361089
USD
100.99
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Amedisys, Inc. stock-summary
stock-summary
Amedisys, Inc.
Pharmaceuticals & Biotechnology
Amedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. The Company owns and operates approximately 524 centers in 39 states and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness, such as heart disease, pulmonary disease, Alzheimer's and Human Immunodeficiency Virus (HIV)/Acquired Immuno Deficiency Syndrome (AIDS). The Personal care segment provides patients with assistance with the essential activities of daily living.
Company Coordinates stock-summary
Company Details
3854 American Way Ste A , BATON ROUGE LA : 70816-4013
stock-summary
Tel: 1 225 29220311 855 2592046
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Paul Kusserow
Chairman of the Board, President, Chief Executive Officer
Mr. Richard Lechleiter
Lead Independent Director
Ms. Ivanetta Samuels
Director
Ms. Vickie Capps
Independent Director
Dr. Molly Coye
Independent Director
Ms. Julie Klapstein
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
622 Million
(Quarterly Results - Jun 2025)
Net Profit:
29 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3,308 Million (Small Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

99.64%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

15.00%

stock-summary
Price to Book

2.68